VA

Vikas Aggarwal

Active Director Director DIN 07056765
DIN 07056765 First appointment Mar 2015 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2015
Shareholding value •••• Premium profile

About Vikas Aggarwal

Data last updated:

Vikas Aggarwal is a Director at Medprio Life Sciences Private Limited (since 2015). The company operates in Healthcare. Medprio Life Sciences Private Limited reported revenue of ₹3.29 Cr (FY 2025).

DIN 07056765
Primary Designation Director
Industry Healthcare
First Appointment 09 Mar 2015
Oldest Company Age 11 yrs
Largest company Medprio Life Sciences Private Limited · ₹3.29 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Mar 20152015₹3.29 Cr (FY 2025)Active

Board colleagues of Vikas Aggarwal

Directorship timeline

Open interactive timeline →
Medprio Life Sciences Private Limited
Premium access

Shareholding and investment profile for Vikas Aggarwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vikas Aggarwal

Vikas Aggarwal currently holds 1 directorship: Medprio Life Sciences Private Limited (Director, since 09 Mar 2015, revenue ₹3.29 Cr (FY 2025)).

Vikas Aggarwal was first appointed on 09 Mar 2015 as Director at Medprio Life Sciences Private Limited.

The current boards of Vikas Aggarwal's companies include Babita Bansal (Medprio Life Sciences Private Limited), Nanu Ram Aggarwal (Medprio Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available